Butyrylcholinesterase (Plasma Derived)
Large Intestine Disorder
University Hospital of Patrasprotein_peptideUnknownDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Large Intestine Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ringer'S Acetate Joachim Zdolsek | Phase 4 | BB |
Normal Human Serum Albumin Joachim Zdolsek | Phase 4 | BB |
Dexasone University of Saskatchewan | Phase 1/2 | CCC |
Moviprep Russian Society of Colorectal Surgeons | N/A | D |
Eziklen® Russian Society of Colorectal Surgeons | N/A | D |
Same molecule, other indications
Butyrylcholinesterase (Plasma Derived) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →